WitrynaExhibit (b)-(14) EXECUTION VERSION . CONFIDENTIAL INTERIM INVESTORS AGREEMENT . This Interim Investors Agreement (this “Agreement”) is made as of August 14, 2015 by and among Dr. Ge Li (the “Chairman”) (solely for the purposes of Section 2.1 and Section 3), G&C Partnership L.P., an exempted limited partnership … Witryna11 kwi 2024 · Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal. Year. On April 11, 2024, the Board of Directors (the "Board") of Anavex Life Sciences Corp., a Nevada corporation (the "Company"), determined that it was in the best interests of the Company and its stockholders to amend and restate the …
Nisa Leung 梁颕宇 - Managing Partner - Qiming Venture Partners …
WitrynaWuXi Biologics is a global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, … WitrynaLife Sciences. AdvanSure™ AlloScreen; AdvanSure™ AlloScreen Max108 Panel; ... LG Chem (China) Investment Co.,Ltd. Tel. +86-10-5120-8209 22nd floor, West Tower, LG Twin Towers, B-12 Jianguomenwai Avenue, ... Leyou New Energy Materials (Wuxi) Co.,Ltd. Tel. +86-182-6152-6162 No.167 Ximei Road, Xinwu District, Wuxi, Jiangsu. chopawatt eleventhhousesolutions.com
2359: WuXi AppTec Co., Ltd. - Summary Jitta
WitrynaInterim Investors Agreement, by and among Dr. Ge Li, G&C Partnership L.P., ABG II-WX Limited, Boyu Capital Fund II, L.P., Temasek Life Sciences Private Limited, Hillhouse Capital Fund II, L.P., Ping An Life Insurance Company of China, Ltd., New WuXi Life Science Holdings Limited, New WuXi Life Science Limited, and WuXi … Witryna5 kwi 2024 · Item 1.01. Entry into a Material Definitive Agreement. On April 5, 2024, 180 Life Sciences Corp., a Delaware corporation (the "Company"), entered into a securities purchase agreement (the "Purchase Agreement") with a certain institutional investor (the "Purchaser"), pursuant to which the Company agreed to issue and sell to the … WitrynaNisa Leung is a Managing Partner of Qiming Venture Partners, leading its health care investments. Nisa has been recognized by the Forbes Global 100 VC Midas List in 2024, 2024, 2024 and 2024, named Top Female Venture Capitalist in China by Forbes in 2024. She currently sits on the board of Zai Lab (NASDAQ:ZLAB; HKSE:9688), … chop awakened aopg